Quarterly Result17 Aug 2026, 05:00 pm
Indrayani Biotech declares Audited FY26 Results
AI Summary
Indrayani Biotech Ltd announced its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The Board of Directors approved these results in a meeting held on August 17, 2026. The company will publish the results in newspapers and on its website, as well as on the BSE website. The auditors' report includes a qualified opinion due to uncertainties regarding trade receivables, loans, and the consolidation of subsidiaries based on Indian GAAP instead of IND AS.
Key Highlights
- Audited standalone and consolidated financial results for FY26 declared.
- Board of Directors approved the results on August 17, 2026.
- Auditors issued a qualified opinion on the consolidated results.
- Uncertainties noted in trade receivables and subsidiary consolidation.
Price Impact
More from INDRANIB